The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-17 of 17 articles
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial
Kok M,
Zocca P,
Buiten R,
Danse PW,
Schotborgh C,
Scholte M,
Hartmann M,
Stoel M,
van Houwelingen K,
Linssen GCM,
Doggen CJM,
von Birgelen C
October 19, 2018 | 10.4244/EIJ-D-18-00336
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population
Kok M,
von Birgelen C,
Sattar N,
Zocca P,
Löwik M,
Danse PW,
Schotborgh C,
Scholte M,
Hartmann M,
Kant GD,
Doelman CJA,
Gin M,
Stoel M,
van Houwelingen K,
Linssen GCM,
IJzerman M,
Doggen CJM,
van der Heijden LC
October 12, 2018 | 10.4244/EIJ-D-17-01067
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
Zocca P,
van der Heijden LC,
Kok M,
Löwik M,
Hartmann M,
Stoel M,
Louwerenburg H,
de Man F,
Linssen GCM,
Knottnerus I,
Doggen CJM,
van Houwelingen K,
von Birgelen C
November 20, 2017 | 10.4244/EIJ-D-17-00634
Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial
van der Heijden LC,
Kok M,
Löwik M,
Danse PW,
Jessurun G,
Hautvast R,
van Houwelingen K,
Stoel M,
Hartmann M,
Linssen GCM,
Doggen CJM,
von Birgelen C
April 20, 2017 | 10.4244/EIJ-D-16-00571
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial
Tandjung K,
Lam MK,
Sen H,
de Man F,
Louwerenburg H,
Stoel M,
van Houwelingen K,
Linssen GCM,
van der Palen J,
Doggen CJM,
von Birgelen C
July 20, 2016 | 10.4244/EIJY15M08_01
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial
Lam MK,
Tandjung K,
Sen H,
Basalus M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
Linssen GCM,
Said S,
Nienhuis M,
de Man F,
van der Palen J,
von Birgelen C
June 19, 2015 | 10.4244/EIJV11I2A32
Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial
Sen H,
Lam MK,
Tandjung K,
Basalus M,
de Man F,
Louwerenburg H,
Stoel M,
van Houwelingen K,
Löwik M,
Linssen GCM,
Said S,
Nienhuis M,
Verhorst P,
van der Palen J,
von Birgelen C
October 20, 2014 | 10.4244/EIJV10I6A117
Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents
Sen H,
Tandjung K,
Basalus M,
L M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
de Man F,
Linssen GCM,
Nijhuis R,
Nienhuis M,
Verhorst P,
van der Palen J,
von Birgelen C
October 26, 2012 | 10.4244/EIJV8I6A104
Giant coronary aneurysm in Churg-Strauss syndrome
October 26, 2012 | 10.4244/EIJV8I6A116
Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry
de Man F,
Tandjung K,
Hartmann M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
Basalus M,
Sen H,
Löwik M,
von Birgelen C
July 27, 2012 | 10.4244/EIJV8I3A52
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay
Heestermans A,
de Boer M,
van Werkum J,
Mosterd A,
Gosselink A,
Dambrink J,
van Houwelingen K,
Koopmans P,
Hamm C,
Zijlstra F,
ten Berg J,
van't Hof A
August 30, 2011 | 10.4244/EIJV7I4A73
Impact of dye injection on intracoronary pressure
June 30, 2009 | 10.4244/EIJV5I2A42
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023